Clinical Observations and Evidence Recent clinical data published in the New England Journal of Medicine demonstrated that standard-dose semaglutide administration resulted in an average 15% reduction in body weight over 68 weeks
When patients lose weight rapidly they can also lose significant muscle mass, putting them at higher risk for sarcopenic obesity and other long-term health consequences
Hair is not essential for survival, he adds
Rather than offering a one-size-fits-all solution, we use this foundational information to design a highly customized GLP-1 treatment plan that fits seamlessly into your routine, ensuring the approach is both safe and specifically targeted to help you achieve sustainable, long-term weight loss
Pucciarelli, G., Mastursi, M., Latte, S., Sacra, C., Setaro, A., Lizzadro, A., and Nolfe, G